Real-world effectiveness of casirivimab plus indevimab in a dedicated ambulatory unit created for patients with early COVID-19 during a massive delta variant wave.
Eur J Clin Microbiol Infect Dis
; 41(8): 1145-1149, 2022 Aug.
Article
em En
| MEDLINE
| ID: mdl-35896762
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tratamento Farmacológico da COVID-19
Limite:
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article